C. Favary

Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study.

H. Maillard, R. Lassalle, A. Taïeb, 2021, Journal of Investigative Dermatology.

Pharmacological treatment patterns in heart failure: a population-based cohort study

N. Moore, R. Lassalle, J. Jové, 2019, European Journal of Clinical Pharmacology.

Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer

A. Tchalla, P. Noize, J. Jové, 2023, Targeted Oncology.

Risk of cancer with immunosuppressants compared to immunomodulators in multiple sclerosis: A nested case–control study within the French nationwide claims database

R. Lassalle, P. Blin, E. Boutmy, 2023, Pharmacoepidemiology and drug safety.